ColoSense: Advancing Noninvasive Colorectal Cancer Screening Through Innovative Diagnostics

Описание: In the inaugural event of the Global Cancer Movement, initiated by OncoDaily, Dr. Erica Barnell, Co-Founder and Chief Medical & Science Officer of Genoscopy, introduced the FDA-approved Colosense test, a groundbreaking advancement in colorectal cancer screening and prevention.

The virtual event, held from December 6-8, 2024, brought together experts to discuss transformative innovations in cancer care.

Key highlights include:
✨ The cutting-edge use of RNA biomarkers for non-invasive detection of colorectal cancer and precancerous lesions.
🌟 Exceptional sensitivity tailored for average-risk individuals aged 45 and older.
📊 Clinical validation results highlighting Colosense's effectiveness in early detection.
🔬 The launch of the Colosense navigation program, bridging gaps in patient care and improving outcomes.
🎯 Dr. Barnell’s inspiring journey in founding Genoscopy and leading impactful advancements in diagnostics.

This session emphasized how Colosense is revolutionizing colorectal cancer screening and empowering prevention strategies, offering new hope for improved patient care.

Don’t miss this enlightening discussion from the Global Cancer Movement virtual event, where innovation and patient-centered solutions take center stage!

#Cancer #Oncology #GlobalCancerMovement #OncoDaily #ColorectalCancer #CancerScreening #Biomarkers #ColorectalCancerPrevention #FDAApproved #EarlyDetection #PatientCare #CancerInnovation #CancerDiagnostics #Genoscopy

SUBSCRIBE to get the latest #oncodaily    / @oncodailytv  

Visit the OncoDaily Website : https://oncodaily.com
Like OncoDaily on LinkedIn:   / oncodaily  
Like OncoDaily on X (Twitter): https://x.com/oncodaily
Follow OncoDaily on Instagram:   / oncodailynews  
Follow OncoDaily on TikTok:   / oncodaily  
Like OncoDaily on Facebook:   / oncodaily  

SUBSCRIBE to OncoDaily Newsletter: https://oncodaily.com/submit-newsletter

About OncoDaily
OncoDaily is a world-leading oncology media platform, which is based in the United States and features the cancer related latest news, insights, and patient stories from around the globe. The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we.”